NCT06504394
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06504394
Title A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | POL | NZL | GBR | ESP | DEU | AUS

Facility Status City State Zip Country Details
University of Iowa-Holden Comprehensive Cancer Center ( Site 0115) Iowa City Iowa 52242 United States Details
University of Iowa - Waukee ( Site 0111) Waukee Iowa 50263 United States Details
Comprehensive Cancer Centers of Nevada ( Site 0114) Las Vegas Nevada 89169 United States Details
Clinical Research Alliance ( Site 0101) Westbury New York 11590 United States Details
Westmead Hospital ( Site 0901) Westmead New South Wales 2145 Australia Details
IC La Serena Research ( Site 0204) La Serena Coquimbo Region 1720430 Chile Details
FALP ( Site 0207) Santiago Region M. de Santiago 7500921 Chile Details
Clínica Inmunocel ( Site 0201) Santiago Region M. de Santiago 7580206 Chile Details
Bradfordhill-Clinical Area ( Site 0202) Santiago Region M. de Santiago 8420383 Chile Details
Biocenter ( Site 0203) Concepción Región del Biobío 4070196 Chile Details
Universitaetsklinikum Essen ( Site 1302) Essen North Rhine-Westphalia 45147 Germany Details
Health Pharma Professional Research S.A. de C.V: ( Site 0403) Mexico City Mexico City 03100 Mexico Details
Centro de Investigacion Clinica de Oaxaca ( Site 0405) Oaxaca City 68020 Mexico Details
Auckland City Hospital ( Site 1001) Auckland 1023 New Zealand Details
Pratia MCM Krakow ( Site 0503) Krakow Lesser Poland Voivodeship 30-727 Poland Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site 0501) Warsaw Masovian Voivodeship 02-781 Poland Details
Uniwersyteckie Centrum Kliniczne-Klinika Hematologii i Transplantologii ( Site 0502) Gdansk Pomeranian Voivodeship 80-214 Poland Details
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 0504) Gliwice Silesian Voivodeship 44-102 Poland Details
Seoul National University Hospital-Oncology ( Site 1101) Seoul 03080 South Korea Details
Institut Català d'Oncologia - L'Hospitalet-Haematology Department ( Site 0703) L'Hospitalet Del Llobregat Barcelona 08908 Spain Details
Hospital Universitario de Salamanca ( Site 0702) Salamanca Castille and León 37007 Spain Details
Hospital Universitario 12 de Octubre-Hemathology and hemotherapy ( Site 0701) Madrid 28041 Spain Details
Ankara Universitesi Tıp Fakultesi Hastanesi ( Site 0801) Ankara 06100 Turkey (Türkiye) Details
Hacettepe Universite Hastaneleri ( Site 0802) Ankara 06230 Turkey (Türkiye) Details
Ondokuz Mayıs Universitesi ( Site 0803) Samsun 55270 Turkey (Türkiye) Details
Glan Clwyd Hospital ( Site 0602) Bodelwyddan Denbighshire LL18 5UJ United Kingdom Details
University College London Hospital ( Site 0605) London London, City of NW1 2PG United Kingdom Details
Churchill Hospital ( Site 0604) Oxford Oxfordshire OX3 7LE United Kingdom Details
The Christie NHS Foundation Trust ( Site 0603) Manchester m20 4bx United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field